SIRT1 and liver dysplastic nodule: The levels of pAMPK and sirtuin-1 are lower in diabetic kidney, but the phosphodiesterase type 4 (PDE4) inhibitor roflumilast mimics the effects of CR to restore the levels of pAMPK/sirtuin-1 and alleviate DN [52].